Form 4 for OFIX Orthofix Medical Inc.
Accepted 2023-01-09 00:00:00 ET · period of report 2023-01-05 · accession 0001209191-23-002642 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-01-09 | 2023-01-05 | OFIX | Valentine Keith | Pres, CEO, Dir | A - Grant | $0.00 | +140.5K | 399.9K | +54% | $0 |
| D | 2023-01-09 | 2023-01-05 | OFIX | Valentine Keith | Pres, CEO, Dir | A - Grant | $0.00 | +338.3K | 338.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-01-05 | A | A | 140,515 | $0.00 | 399,855 | D | — | — | (F1) The restricted stock units vest with respect to one-third (1/3rd) of the shares of stock covered hereby on each of the first, second and third anniversaries of the Grant Date. (F2) Includes 260,896 unvested restricted stock units. |
| 2 | Derivative | Employee Stock Option (Right to Buy) | 2023-01-05 | A | A | 338,264 | $0.00 | 338,264 | D | $20.90 · — to 2033-01-05 | 338,264 Common Stock | (F3) The options vest and become exercisable with respect to one-third (1/3rd) of the shares covered thereby on the first anniversary of the Grant Date and one-twelfth (1/12th) of the shares covered thereby on each of the 15-month, 18-month, 21-month, 24-month, 27-month, 30-month, 33-month and 36-month anniversaries of the Grant Date. |